| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |